The drug reportedly reduces patients’ dependence on oxygen and hastens their recovery. It was developed by a laboratory of India’s Defence Research and Development Organisation (DRDO) and Hyderabad-based pharmaceutical company, Dr Reddy’s Laboratories. The distribution of the new drug started on Monday. The first batch of the drug was released by India’s Defence Minister, Rajnath Singh, and the Health Minister, Harsh Vardhan, in the Indian capital and would be initially used in hospitals in the city. Some experts have however questioned the efficacy of the new drug, saying not enough evidence has been published from the stage two and three of clinical trials.
India releases new drug for COVID-19 treatment
tribuneonlineng.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneonlineng.com Daily Mail and Mail on Sunday newspapers.
কোভিড-১৯: ভারতে শনাক্ত নতুন রোগীর সংখ্যা ৩ লাখের নিচে নামল
bdnews24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bdnews24.com Daily Mail and Mail on Sunday newspapers.
Air India ferrying Zeolite for DRDO to boost oxygen production ANI | Updated: May 15, 2021 13:24 IST
By Ashoke Raj
New Delhi [India], May 15 (ANI): To meet the demand of oxygen supply in the country amidst the COVID-19 pandemic, India s Defence Research and Development Organisation (DRDO) has chartered the National Carrier Air India (AI) to import Zeolite from different countries. Government of India is in the process of importing Zeolite from different parts of the world, for use in Pressure Swing Absorption (PSA) plants to boost oxygen supplies in the country. DRDO has been appointed by GOI as a charterer for these consignments. Air India will bring in zeolite for DRDO from different parts of the world, Air India spokesperson told ANI.